The 2021-2026 World Outlook for Melanoma Therapeutics
This study covers the world outlook for melanoma therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each c...
11/27/2019 | World Outlook 2180
The 2021-2026 World Outlook for Colorectal Cancer Treatments
This study covers the world outlook for colorectal cancer treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within...
11/27/2019 | World Outlook 2179
The 2021-2026 World Outlook for Asthma Treatments
This study covers the world outlook for asthma treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each count...
11/27/2019 | World Outlook 2178
The 2021-2026 World Outlook for Biosimilars
This study covers the world outlook for biosimilars across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each country and...
11/27/2019 | World Outlook 2177
The 2021-2026 World Outlook for Type 2 Diabetes Mellitus Treatments
This study covers the world outlook for type 2 diabetes mellitus treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics...
11/27/2019 | World Outlook 2176
The 2021-2026 World Outlook for Hepatitis B Therapeutics
This study covers the world outlook for hepatitis B therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within eac...
11/27/2019 | World Outlook 2175
The 2021-2026 World Outlook for Breast Cancer Treatments
This study covers the world outlook for breast cancer treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within eac...
11/27/2019 | World Outlook 2174
The 2021-2026 World Outlook for Type 1 Diabetes Mellitus (T1DM) Treatments
This study covers the world outlook for type 1 diabetes mellitus (T1DM) treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic d...
11/27/2019 | World Outlook 2173
The 2021-2026 World Outlook for Immunology Treatments
This study covers the world outlook for immunology treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each c...
11/27/2019 | World Outlook 2172
The 2021-2026 World Outlook for Pancreatic Cancer Treatments
This study covers the world outlook for pancreatic cancer treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within...
11/27/2019 | World Outlook 2171
